SSII.O (SSII.O) News
Follow SSII.O (SSII.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
SS Innovations submits FDA response with final data from expanded SSi Mantra clinical, human factors study
SS Innovations submitted its response on Oct. 5, 2026 to an FDA request tied to its SSi Mantra 510(k) filing. Results have already been provided to the FDA, including final data from an expanded human clinical and human-
REGULATION | Oct 13, 2026, 01:30 PM UTC
L
SS Innovations submits response to FDA information request on SSi Mantra 510(k) filing
SS Innovations submitted its response to an FDA request for additional information on its 510(k) filing for the SSi Mantra. The package includes final data from expanded human clinical and human factors validation work,
REGULATION | Oct 13, 2026, 12:35 PM UTC
L
SS Innovations sells USD 21.03 million secured convertible promissory note in debt offering
SS Innovations priced a USD 20 million secured convertible promissory note offering to an institutional investor. Note principal totals USD 21.03 million, reflecting a USD 1 million original issue discount, USD 25,000 tr
REGULATION | Oct 13, 2026, 10:06 AM UTC